Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-14-007688
Filing Date
2014-11-03
Accepted
2014-11-03 17:06:38
Documents
3
Period of Report
2014-11-03

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT pre14a1114_actiniumpharm.htm PRE 14A 511478
2 GRAPHIC image_002.jpg GRAPHIC 16585
3 GRAPHIC img1.jpg GRAPHIC 3961
  Complete submission text file 0001213900-14-007688.txt   541160
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36374 | Film No.: 141190228
SIC: 2834 Pharmaceutical Preparations